Healthcare provider profile · identity verified

Carl Roth

Internal Medicine · SILVER CREEK, NY · NPI 1942303029

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	743	179
Lisinopril	Lisinopril	447	119
Levothyroxine Sodium	Levothyroxine Sodium	408	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	335	48
Amlodipine Besylate	Amlodipine Besylate	331	87
Omeprazole	Omeprazole	323	82
Eliquis	Apixaban	292	42
Metformin Hcl	Metformin Hcl	281	68
Metoprolol Succinate	Metoprolol Succinate	262	72
Gabapentin	Gabapentin	238	45
Rosuvastatin Calcium	Rosuvastatin Calcium	224	55
Simvastatin	Simvastatin	207	46
Furosemide	Furosemide	204	38
Ibuprofen	Ibuprofen	176	44
Pantoprazole Sodium	Pantoprazole Sodium	176	39
Tamsulosin Hcl	Tamsulosin Hcl	159	33
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	158	44
Jardiance	Empagliflozin	154	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	146	25
Albuterol Sulfate Hfa	Albuterol Sulfate	144	47
Oxycodone Hcl	Oxycodone Hcl	144	14
Sertraline Hcl	Sertraline Hcl	131	27
Potassium Chloride	Potassium Chloride	130	11
Xarelto	Rivaroxaban	129	19
Clopidogrel	Clopidogrel Bisulfate	128	28
Trazodone Hcl	Trazodone Hcl	126	17
Metoprolol Tartrate	Metoprolol Tartrate	124	30
Carvedilol	Carvedilol	115	20
Duloxetine Hcl	Duloxetine Hcl	103	21
Meloxicam	Meloxicam	98	25
Pregabalin	Pregabalin	92	12
Ezetimibe	Ezetimibe	90	26
Tramadol Hcl	Tramadol Hcl	90	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	88	suppressed
Prednisone	Prednisone	88	60
Ozempic	Semaglutide	86	14
Baclofen	Baclofen	85	13
Famotidine	Famotidine	84	18
Pravastatin Sodium	Pravastatin Sodium	79	15
Alprazolam	Alprazolam	74	17
Mirtazapine	Mirtazapine	73	suppressed
Warfarin Sodium	Warfarin Sodium	69	12
Allopurinol	Allopurinol	67	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	20
Benazepril Hcl	Benazepril Hcl	61	18
Metformin Hcl Er	Metformin Hcl	60	14
Irbesartan	Irbesartan	59	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	12
Atenolol	Atenolol	58	17
Hydrochlorothiazide	Hydrochlorothiazide	57	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	56	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	56	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	17
Losartan Potassium	Losartan Potassium	53	18
Celecoxib	Celecoxib	52	15
Zolpidem Tartrate	Zolpidem Tartrate	50	12
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Alendronate Sodium	Alendronate Sodium	47	11
Amoxicillin	Amoxicillin	46	35
Spironolactone	Spironolactone	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Doxepin Hcl	Doxepin Hcl	43	suppressed
Farxiga	Dapagliflozin Propanediol	43	18
Fentanyl	Fentanyl	43	suppressed
Fenofibrate	Fenofibrate	42	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Divalproex Sodium	Divalproex Sodium	39	suppressed
Risperidone	Risperidone	39	suppressed
Aripiprazole	Aripiprazole	37	suppressed
Myrbetriq	Mirabegron	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	24
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	12
Montelukast Sodium	Montelukast Sodium	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Finasteride	Finasteride	31	11
Fenofibrate	Fenofibrate,micronized	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Otezla	Apremilast	29	suppressed
Letrozole	Letrozole	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Latanoprost	Latanoprost	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Cephalexin	Cephalexin	26	12
Soliqua 100-33	Insulin Glargine/Lixisenatide	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	22
Glimepiride	Glimepiride	25	suppressed
Cholestyramine	Cholestyramine (With Sugar)	24	suppressed
Rexulti	Brexpiprazole	23	suppressed
Azithromycin	Azithromycin	22	20
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Olanzapine	Olanzapine	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	20
Clonidine Hcl	Clonidine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	12
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Nystatin	Nystatin	16	13
Clonazepam	Clonazepam	15	suppressed
Constulose	Lactulose	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Lactulose	Lactulose	15	suppressed
Diazepam	Diazepam	14	suppressed
Digoxin	Digoxin	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Cimetidine	Cimetidine	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Naproxen	Naproxen	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Desonide	Desonide	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Primidone	Primidone	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Valsartan	Valsartan	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error